Cadence Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-27,593
| Closed | -$517K | – | 675 |
|
2018
Q1 | $517K | Buy |
27,593
+2,908
| +12% | +$54.5K | 0.03% | 500 |
|
2017
Q4 | $475K | Buy |
24,685
+1,782
| +8% | +$34.3K | 0.03% | 506 |
|
2017
Q3 | $409K | Sell |
22,903
-16,265
| -42% | -$290K | 0.03% | 539 |
|
2017
Q2 | $700K | Sell |
39,168
-23,619
| -38% | -$422K | 0.05% | 438 |
|
2017
Q1 | $910K | Buy |
62,787
+38,303
| +156% | +$555K | 0.06% | 380 |
|
2016
Q4 | $451K | Buy |
24,484
+544
| +2% | +$10K | 0.03% | 533 |
|
2016
Q3 | $454K | Buy |
+23,940
| New | +$454K | 0.03% | 500 |
|